A 100% human milk-based fortifier from Prolacta® Bioscience
A new option for human milk-based nutrition
First fortifier indicated for use in term infants.
Research. Recovery. Results.
Achieving adequate growth and weight gain is critical for healthy development in critically ill infants requiring a corrective surgical procedure. Developed by Prolacta Bioscience®, Surgifort® is the first and only 100% human milk-based fortifier intended for term infants with gastroschisis who have undergone a corrective procedure.
Nutritional benefits, as part of an EHMD
As a human milk–based, human milk fortifier, Surgifort is designed to meet the nutritional needs of full-term infants undergoing corrective surgery for gastroschisis. An Exclusive Human Milk Diet (EHMD) is achieved when 100% of protein, fat, and carbohydrate are derived from human milk; This diet includes a human milk–based fortifier. When used as part of an EHMD, and added to mother’s own milk or to donor human milk, Surgifort fortifier provides an appropriate amount of calories, protein, and minerals† required for infants to grow and heal. The ability to concentrate Surgifort fortifier ensures that nutritional needs can be met even when fluids are restricted.
Nutrition is an important detail
As part of Prolacta dedication to improving outcomes for critically ill infants, for over twenty years, Prolacta’s human milk-based nutritional products have helped adequately feed premature infants all over the world. When used as part of an EHMD in clinical studies, Prolacta human milk-based fortifiers for preterm infants have been shown to:
- Achieve adequate growth1
Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459. doi:10.1186/1756-0500-6-459
2Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk-based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300
3Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤ 1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054
- Reduce the incidence of necrotizing enterocolitis4
Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168
5Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134. Published correction appears in Breastfeed Med. 2017;12(10):663. doi:10.1089/bfm.2015.0134.correx
- Reduce feeding intolerance4
Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168
- Shorten time to achieve full feeds4
Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168
Now we’re bringing the power of human milk to critically ill term infants with gastroschisis, requiring corrective surgical procedure. For more information about Surgifort® fortifier or the Exclusive Human Milk Diet (EHMD), please contact your Prolacta representative.
Clinician-to-clinician guidance
Clinician-to-clinician guidance
Support with an existing order
Citations
1 Hair AB, Hawthorne KM, Chetta KE, Abrams SA. Human milk feeding supports adequate growth in infants ≤ 1250 grams birth weight. BMC Res Notes. 2013;6:459. doi:10.1186/1756-0500-6-459
2 Huston R, Lee M, Rider E, et al. Early fortification of enteral feedings for infants <1250 grams birth weight receiving a human milk diet including human milk-based fortifier. J Neonatal Perinatal Med. 2020;13(2):215-221. doi:10.3233/NPM-190300
3 Huston RK, Markell AM, McCulley EA, Gardiner SK, Sweeney SL. Improving growth for infants ≤ 1250 grams receiving an exclusive human milk diet. Nutr Clin Pract. 2018;33(5):671-678. doi:10.1002/ncp.10054
4 Assad M, Elliott MJ, Abraham JH. Decreased cost and improved feeding tolerance in VLBW infants fed an exclusive human milk diet. J Perinatol. 2016;36(3):216-220. doi:10.1038/jp.2015.168
5 Hair AB, Peluso AM, Hawthorne KM, et al. Beyond necrotizing enterocolitis prevention: improving outcomes with an exclusive human milk-based diet. Breastfeed Med. 2016;11(2):70-74. doi:10.1089/bfm.2015.0134. Published correction appears in Breastfeed Med. 2017;12(10):663. doi:10.1089/bfm.2015.0134.correx